Clinical Trial Update: Nab-paclitaxel in Metastatic Breast Cancer Patients Failing Solvent Based Taxane (Tiffany) [Phase 2]

View source ↗

Summary

Phase 2 trial of nab-paclitaxel in metastatic breast cancer patients who failed solvent-based taxanes has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Nab-paclitaxel (paclitaxel protein-bound)

Snippet

Sponsor: GBG Forschungs GmbH | Conditions: Metastatic Breast Cancer | Phase 2 | Status: TERMINATED